| HOME >> BIOLOGY >> TECHNOLOGY |
Pursing International Market Opportunities for the Company's Medical
Countermeasures
ANNAPOLIS, Md., Aug. 11 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that Lord Lewis Moonie has joined the Company as a special UK government advisor.
Lord Moonie will assist PharmAthene in exploring interest and support for the Company's biodefense programs and product candidates within the UK government.
"We are honored to welcome Lord Moonie to PharmAthene in this advisory capacity and are delighted to have the opportunity to leverage his significant knowledge of the UK biodefense industry and amongst our NATO allies," stated David P. Wright, President and Chief Executive Officer of PharmAthene. "Lord Moonie's medical background and extensive experience as a Member of Parliament, as well as his oversight of the Research Establishment at Porton Down, which included recombinant vaccines for plague and anthrax, will be invaluable to us as we continue to expand awareness and the market for our biodefense countermeasures among our Allies. We view Lord Moonie's appointment as an important step in the execution of our international strategy to meet the urgent needs of nations internationally requiring medical countermeasures."
Lord Moonie retired from the UK's House of Common in 2005 after
eighteen years as Member of Parliament for Kirkcaldy. During this time,
Lord Moonie spent three and a half years as a junior minister in the
Ministry of Defence (MOD), with responsibility for all of MOD's Science and
Technology, including the Defence Diversification Agency. Prior to this he
wa
'/>"/>
| SOURCE PharmAthene, Inc. Copyright©2008 PR Newswire. All rights reserved |